Stay updated with breaking news from Pratima Reddy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dhananjay Singh took over effective April 1, 2024 from Sreenath NS, who is retiring after 36 years of service with Merck in India, the company said in a statement.
In his role as the managing director, Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other leaders from Merck's businesses in India. He joined Sigma-Aldrich in 1997. Over the years he took on several leadership roles in commercial organisations before his appointment as head of science and lab solutions commercial for India, a position he held since 2022.
In his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance alongside other leaders from Merck's businesses in India.
Merck, a leading science and technology company, recently announced the appointment of Dhananjay Singh as the Managing Director of Merck Life Science in India, in addition to his current position as Head of Science & Lab Solutions Commercial, India.
Merck has appointed Pratima Reddy as its country speaker for India. Reddy, who is currently the GM and managing director of Merck Specialities India, will also take on this new role. She aims to uphold the Merck brand, strengthen industry relations, and collaborate with leaders across the companys businesses. Reddy has over 18 years of experience, including 10 in the pharmaceutical industry. Sreenath NS, the outgoing country speaker, will focus on scaling the shared business services division to new heights.